CVS Health Inc. (NYSE:CVS) said Thursday it is taking additional steps to reduce prescription drug costs by expanding access to biosimilar medications, and announced new formulation changes that will take effect in 2026. Beginning April 1, 2026, CVS Caremark will add the osteoporosis biosimilars Ospomyv and Stoboclo, along with the generic teriparatide products Bonsity and […]
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their trades here at Benzinga on our options activity scanner. Traders will look for circumstances where the market estimate of an option deviates significantly from its normal value. High amounts of trading […]